Finance

Lists
Why is ATHE down 6,44%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
1,96 $
-6,44%
(-0,13) 1D
1,96 $
0,00% (0,00)
After hours
Closed: 13 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
2,04 $
High
2,14 $
Low
1,70 $
Mkt. cap
36,60 մլն
Avg. vol.
165,56 հզր
Volume
109,69 հզր
52-wk high
5,89 $
52-wk low
1,70 $
EPS
-0,91 $
Beta
0,39
Shares outstanding
19,10 մլն
No. of employees
11
Open
2,04 $
High
2,14 $
Low
1,70 $
Mkt. cap
36,60 մլն
Avg. vol.
165,56 հզր
Volume
109,69 հզր
52-wk high
5,89 $
52-wk low
1,70 $
EPS
-0,91 $
Beta
0,39
Shares outstanding
19,10 մլն
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
HeadquartersՄելբուրն, Վիկտորիա, Ավստրալիա
SectorHealth Care
Industry-
Websitealteritytx.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current 1,96 $
16,00 $ (+716,33%)
Average
13,67 $ (+597,45%)
Lowest
10,00 $ (+410,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
10,00 $
+410,2%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
15,00 $
+665,3%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
16,00 $
+716,3%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 $
+410,2%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 $
+410,2%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
12,00 $
+512,2%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,40 մլն
1,40 մլն
403,29 հզր
403,29 հզր
Cost of goods sold
49,43 հզր
49,43 հզր
81,96 հզր
81,96 հզր
Cost of revenue
49,43 հզր
49,43 հզր
81,96 հզր
81,96 հզր
Research and development expenses
3,92 մլն
3,92 մլն
4,89 մլն
4,89 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,56 մլն
2,56 մլն
2,71 մլն
2,71 մլն
Operating expense
6,57 մլն
6,57 մլն
7,65 մլն
7,65 մլն
Total operating expenses
6,62 մլն
6,62 մլն
7,73 մլն
7,73 մլն
Operating income
-5,22 մլն
-5,22 մլն
-7,32 մլն
-7,32 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-4,78 մլն
-4,78 մլն
-6,87 մլն
-6,87 մլն
EBT excluding unusual items
-4,78 մլն
-4,78 մլն
-6,87 մլն
-6,87 մլն
Income tax expense
30,78 հզր
30,78 հզր
25,97 հզր
25,97 հզր
Effective tax rate
-0,64%
-0,64%
-0,38%
-0,38%
Other operating expenses
95,67 հզր
95,67 հզր
46,26 հզր
46,26 հզր
Net income
-4,81 մլն
-4,81 մլն
-6,89 մլն
-6,89 մլն
Net profit margin
-343,00%
-343,00%
-1 709,06%
-1 709,06%
Earnings per share
-
-
-
-
Interest and investment income
454,88 հզր
454,88 հզր
403,45 հզր
403,45 հզր
Interest expense
-
-
-
-
Net interest expenses
454,88 հզր
454,88 հզր
403,45 հզր
403,45 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,22 մլն
-5,22 մլն
-7,32 մլն
-7,32 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps